Streetbeat News

Products Services

HAIL

HMC

Honda Motor Company (NYSE:HMC) is recalling 1.7 million vehicles due to a defect in the steering gearbox, causing increased friction and potential crash risks. This follows previous recalls for airbag and fire risks. HMC shares are down 1.72% premarket.

Portfolio Pulse from Lekha Gupta

October 09, 2024 | 12:55 pm

CLSD

Clearside Biomedical's shares rose following the successful results of its ODYSSEY Phase 2b trial for CLS-AX in treating Neovascular age-related macular degeneration, achieving both primary and secondary outcomes.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 12:52 pm

BCE

FX Innovation, a Bell Canada company, has acquired HGC Technologies to enhance its ServiceNow capabilities, aiming to expand in the U.S. market. This acquisition strengthens FX Innovation's position in digital workflow automation.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 12:51 pm

LQR

LQR House has announced a marketing partnership with Big Spoon to promote its non-alcoholic ready-to-drink (RTD) product line on CWSpirits. The partnership will focus on flavors like Gin & Tonic, Margarita, and Whiskey Ginger, using email, SMS, banner ads, and influencer content campaigns to boost awareness and sales.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 12:48 pm

SONN

Sonnet BioTherapeutics' shares rise following a licensing agreement with Alkem Laboratories for the development and commercialization of SON-080, targeting diabetic peripheral neuropathy.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 12:47 pm

SONN

Sonnet BioTherapeutics has entered a licensing agreement with Alkem Laboratories for the development and commercialization of SON-080 in India, targeting diabetic peripheral neuropathy. Sonnet will receive $1M upfront, up to $1M in milestone payments, and low double-digit royalties on net sales. Alkem will fund and commercialize SON-080 for chemotherapy-induced and autonomic neuropathy in India, with the market expected to grow significantly by 2030.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 12:45 pm

CANF

Can-Fite Biopharma's shares rose following the FDA's orphan drug designation for its drug namodenoson, aimed at treating pancreatic cancer.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 12:40 pm

NVTS

Navitas Semiconductor has expanded its GaNSafe portfolio, which could enhance its market position in the semiconductor industry.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 12:38 pm

SPPL

SIMPPLE Ltd. (NASDAQ:SPPL) has announced new contracts and partnerships in Australia and New Zealand, projected to generate approximately $2.35 million in revenue. These contracts involve providing integrated cleaning services and compliance solutions to various sectors, including aviation, education, manufacturing, and retail.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 12:38 pm

GILD

Gilead Sciences will present new data on its antiviral portfolio at IDWeek 2024, including findings from HIV, COVID-19, and RSV research. Highlights include Phase 3 trial results for HIV prevention and treatment, and real-world evidence supporting Veklury for COVID-19.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 12:36 pm